ANGLE (ANPCF) FCF Margin % : -786.82% (As of Jun. 2023)

View and export this data going back to 2014. Start your Free Trial

What is ANGLE FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ANGLE's Free Cash Flow for the six months ended in Jun. 2023 was $-11.88 Mil. ANGLE's Revenue for the six months ended in Jun. 2023 was $1.51 Mil. Therefore, ANGLE's FCF Margin % for the quarter that ended in Jun. 2023 was -786.82%.

As of today, ANGLE's current FCF Yield % is -44.37%.

The historical rank and industry rank for ANGLE's FCF Margin % or its related term are showing as below:

ANPCF' s FCF Margin % Range Over the Past 10 Years
Min: -1723.05 Med: -1381.05 Max: -255.21
Current: -892.68

During the past 13 years, the highest FCF Margin % of ANGLE was -255.21%. The lowest was -1723.05%. And the median was -1381.05%.

ANPCF's FCF Margin % is ranked worse than
91.89% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.405 vs ANPCF: -892.68

ANGLE FCF Margin % Historical Data

The historical data trend for ANGLE's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE FCF Margin % Chart

ANGLE Annual Data

Trend

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-1,380.23

-1,277.80

-1,096.48

-1,559.61

-1,722.95

ANGLE Semi-Annual Data
	Oct13	Apr14	Oct14	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial															-2,500.96	-1,171.77	-2,641.86	-1,103.56	-786.82

Competitive Comparison of ANGLE's FCF Margin %

For the Diagnostics & Research subindustry, ANGLE's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ANGLE's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ANGLE's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ANGLE's FCF Margin % falls into.

ANGLE FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ANGLE's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-21.847	/	1.268
	=	-1,722.95 %

ANGLE's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-11.881	/	1.51
	=	-786.82 %

ANGLE FCF Margin % Related Terms

Thank you for viewing the detailed overview of ANGLE's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ANGLE (ANPCF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (OTCPK:ANPCF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ANPCY:USA AGL:UK DWV:Germany

Address

10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF

Website

https://www.angleplc.com

ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.

ANGLE (ANPCF) Headlines

From GuruFocus

Angle PLC Announces AACR 2019

By ACCESSWIRE AccessWire • 04-12-2019

Angle PLC Announces Holding(s) in Company - (2)

By ACCESSWIRE ACCESSWIRE • 07-08-2020

Angle PLC Announces Exercise of Options and Total Voting Rights

By ACCESSWIRE ACCESSWIRE • 04-30-2021

Angle PLC Announces Parsortix-Harvested CTCs Uncover Novel Biomarker

By ACCESSWIRE ACCESSWIRE • 02-18-2021

Angle PLC Announces Harvesting CTCs from Brain Metastasis Patients

By ACCESSWIRE ACCESSWIRE • 07-09-2021

Angle PLC Announces Holding(s) in Company - (1)

By ACCESSWIRE ACCESSWIRE • 07-08-2020